We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Smaller Living Donor Liver Grafts Do Not Affect Survival Rates

By HospiMedica International staff writers
Posted on 25 Nov 2009
No significant difference in survival was seen when living donor left side liver grafts of less than 35% of the recipient's standard liver volume (SLV) were used, according to a new study.

Researchers at Shinshu University School of Medicine (Matsumoto, Japan) examined the impact of graft size on several clinical outcomes, including survival. More...
A total of 120 adult recipients of left side liver grafts (either the left lobe alone, or the left lobe with the caudate lobe) were included in the study. Of these, 33 patients received grafts that were less than 35% of their SLV, while 87 other patients received larger grafts. The recipient and donor characteristics of the two groups were similar, except for mean pretransplant prothrombin international normalized ratio (INR) time and mean body weight, which were higher in the group that received the relatively smaller grafts. In all, the average graft volume/recipient SLV ratio was 31.8% in the smaller graft group and 42.5% in the larger graft group.

The researchers found that there were no significant differences in the postoperative serum total bilirubin levels, prothrombin time INR, daily ascites volume, or duration of postoperative hospital stay between the groups. However, the 1-year and 5-year survival rates in the group that received the smaller transplants were 80.7% and 64.2%, respectively, whereas those of the group that received the larger transplants were 90.8% and 84.9%, respectively, with no significant difference between groups. Seven deaths were logged from 1 year to 5 years post-transplantation, and the causes included stroke, recurrent liver cancer, uterine cancer, and sepsis. The study was published in the November 2009 issue of Liver Transplantation.

"Graft size was not considered to be the only cause of so-called small-for-size graft syndrome, and left side grafting appears to be the procedure of choice for adult-to-adult living donor liver transplantation because of the lower risk to donors in comparison with right lobe grafting,” concluded lead author Shinichi Miyagawa, M.D., and colleagues of the department of surgery.

With the extensive use of living donor liver grafts in adult patients, controversy over small-for-size syndrome has escalated in recent years, which remains difficult to diagnose since the symptoms seem to be multifactorial, and are neither specific nor inevitable. The occurrence of small-for-size syndrome seems to depend on a number of recipient and graft factors, as well as potential pathogenic mechanisms that include persistent portal hypertension and portal overperfusion.

Related Links:

Shinshu University School of Medicine




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.